Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > This is why formulations took so long, great strategy!

<< Previous

Bullboard Posts

Next >>

Comment by postie1on Sep 19, 2024 11:46am

93 Views

Post# 36231112

RE:RE:RE:This is why formulations took so long, great strategy!

since she knows the FDA maybe that is closer than we know. I am also wondering if that Vanadium/raincage stuff might be getting closer to advancement stage. Since VM is very closed mouth we will not hear until after the fact.

<< Previous

Bullboard Posts

Next >>

Oil industry trailblazer Sara Akbar discusses her vision for Sonoro